Authorship:
Aurélien Chepy1,2,3,4, *, Marie
Veron4,5, *, Sophie Gautier6,
Meryem-Maud Farhat3,4, Ryadh
Pokeerbux3,7, Giorgia Venturelli3,
Cécile Yelnik2,3,7,8, Sylvain
Dubucquoi1,2,4,9, Céline Podevin3,
Manel Jendoubi1,2,4, Isabelle
Citerne3,4, Jennifer Baraffe3,4,
Delphine Staumont-Sallé1,2,4,5, $, David
Launay1,2,3,4, $, Sébastien
Sanges1,2,3,4
1. Univ. Lille, U1286 - INFINITE - Institute for Translational Research
in Inflammation, F-59000 Lille, France
2. Inserm, F-59000 Lille, France
3. CHU Lille, Département de Médecine Interne et Immunologie Clinique,
F-59000 Lille, France
4. Centre de Référence des Angiœdèmes à Kinines, F-59000 Lille, France
5. CHU Lille, Département de Dermatologie, F-59000 Lille, France
6. Univ. Lille, Inserm, CHU Lille, UMR-S1172, Center for
Pharmacovigilance, F-59000 Lille, France
7. CHU Lille, Département de Médecine Polyvalente Post-Urgences, F-59000
Lille, France
8. Univ. Lille, U1167 - RIDAGE - Risk factors and molecular determinants
of aging-related diseases, F-59000 Lille, France
9. CHU Lille, Laboratoire d’Immunologie, F-59000 Lille, France
*AC and MV contributed equally to this work.
$DSS and DL contributed equally to this work.